Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 Biomarker disease BEFREE These findings suggest that GRIN2B may be associated with schizophrenia and interaction effects of the polymorphisms in hsa-miR-219, CAKM2G, GRIN2B and GRIN3A may confer susceptibility to schizophrenia in the Chinese Han population. 26257337 2015
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 Biomarker disease PSYGENET A population-specific uncommon variant in GRIN3A associated with schizophrenia. 23237318 2013
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 GeneticVariation disease BEFREE A population-specific uncommon variant in GRIN3A associated with schizophrenia. 23237318 2013
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 Biomarker disease PSYGENET We searched for genetic variants in the putative core promoter region and all the exons (including UTR ends) of the GRIN3A gene in 333 Han Chinese patients with schizophrenia and 369 control subjects from Taiwan using direct polymerase chain reaction (PCR) autosequencing, and assessed their association with schizophrenia. 19665356 2009
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 GeneticVariation disease BEFREE We searched for genetic variants in the putative core promoter region and all the exons (including UTR ends) of the GRIN3A gene in 333 Han Chinese patients with schizophrenia and 369 control subjects from Taiwan using direct polymerase chain reaction (PCR) autosequencing, and assessed their association with schizophrenia. 19665356 2009
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 Biomarker disease PSYGENET As was the case in schizophrenia, no changes in NR3A expression were observed in the inferior temporal cortex in bipolar disorder. 15474907 2004
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.340 AlteredExpression disease BEFREE As was the case in schizophrenia, no changes in NR3A expression were observed in the inferior temporal cortex in bipolar disorder. 15474907 2004
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.310 Biomarker disease PSYGENET As was the case in schizophrenia, no changes in NR3A expression were observed in the inferior temporal cortex in bipolar disorder. 15474907 2004
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.310 AlteredExpression disease BEFREE As was the case in schizophrenia, no changes in NR3A expression were observed in the inferior temporal cortex in bipolar disorder. 15474907 2004
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.300 Biomarker disease CTD_human Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. 19295509 2009
CUI: C1305855
Disease: Body mass index
Body mass index
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0596887
Disease: mathematical ability
mathematical ability
0.100 GeneticVariation phenotype GWASCAT Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. 30038396 2018
CUI: C0028043
Disease: Nicotine Dependence
Nicotine Dependence
0.020 GeneticVariation disease BEFREE We performed an association study of 16 single nucleotide polymorphisms (SNPs) in GRIN3A with ND in 2616 Chinese individuals. 30741440 2020
CUI: C0020179
Disease: Huntington Disease
Huntington Disease
0.020 Biomarker disease BEFREE Our data provide proof-of-concept for GluN3A silencing as a beneficial strategy to prevent or reverse corticostriatal disconnectivity and motor impairment in HD and support the use of RNAi-based or small-molecule approaches for harnessing this therapeutic potential. 29914757 2018
CUI: C0020179
Disease: Huntington Disease
Huntington Disease
0.020 Biomarker disease BEFREE Suppressing the GluN3A reactivation corrected the NMDAR hyperfunction and prevented the full range of HD signs and symptoms in mouse models, encouraging efforts to develop GluN3A-selective antagonists and/or explore alternative therapeutic approaches to block GluN3A expression. 25686081 2015
CUI: C0028043
Disease: Nicotine Dependence
Nicotine Dependence
0.020 Biomarker disease BEFREE We concluded that GRIN3A represents a strong candidate for involvement in the etiology of ND and warrants further investigation in independent samples. 20084518 2010
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.010 Biomarker group BEFREE Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases. 30734226 2019
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.010 Biomarker phenotype BEFREE Of these genes, GluN3A has been the most studied, and it has been revealed to play crucial roles in the etiology of addictions. 29429049 2018
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.010 AlteredExpression phenotype BEFREE GluN3A KO mice displayed abnormal food preference in the social transmission of food preference task and low social interaction activity in the five-trial social memory test, but without social memory deficits. 29554474 2018
Congenital Disorders of Glycosylation
0.010 GeneticVariation group BEFREE We also found (either using a panel of inhibitors or by studying human fibroblasts derived from patients with a congenital disorder of glycosylation) that <i>N</i>-glycan remodeling is not required for the surface delivery of GluN3A-containing NMDARs. 29915530 2018
CUI: C0347197
Disease: Benign neoplasm of oral cavity
Benign neoplasm of oral cavity
0.010 Biomarker group BEFREE The peptide mass at 2,316 Da of Notch1 appeared in early-stage OM and benign oral tumors while the peptide mass at 2,505 Da of glutamate ionotropic receptor N-methyl-D-aspartate type subunit 3A (GRIN3A) was identified in all groups. 30001383 2018
CUI: C1510472
Disease: Drug Dependence
Drug Dependence
0.010 AlteredExpression group BEFREE However, unlike our earlier finding of drug addiction, the mRNA expression levels of GluN3A and GluN3B subunits in PBLs of game addicts are reduced and unchanged, respectively, compared with control subjects. 29788757 2018
CUI: C0019337
Disease: Heroin Dependence
Heroin Dependence
0.010 GeneticVariation disease BEFREE These results suggest that GRIN3A rs17189632 and GRIN3B rs2240158 may contribute to the susceptibility of heroin addiction. 27542340 2016
CUI: C0265552
Disease: Congenital macrodactylia
Congenital macrodactylia
0.010 Biomarker disease BEFREE GRIN3A and MAPT stimulate nerve overgrowth in macrodactyly. 27840953 2016
CUI: C0011206
Disease: Delirium
Delirium
0.010 GeneticVariation disease BEFREE These findings suggest that the genetic variations of NR3A subunit of NMDA receptor may be a predisposing factor to delirium among the Polish population of cardiac surgery patients. 25041634 2015